Radiotherapy Combined with Focused Ultrasound in the Treatment of Malignant Solid Tumors

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058531

Enrollment

Unknown

Registered

2022-04-10

Start date

2022-04-06

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Solid Tumors

Interventions

Combined Treatment Group 1 (phase 1):Radiotherapy and Focused Ultrasound

Combined Treatment Group 2 (phase 2):Radiotherapy and Focused Ultrasound

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Pathological diagnosis of malignant solid tumor; 2. ECOG score: < 2 points; 3. Aged 18-70 years; 4. The estimated survival time is greater than 3 months.

Exclusion criteria

Exclusion criteria: 1. Skin and soft tissue rupture and infection in the treatment area; 2. The sound channel is less than 1/2; 3. Severe hepatic and renal insufficiency.

Design outcomes

Primary

Measure	Time frame
Complications;Objective Response Rate (ORR) ;Progression Free Survival (PFS);Overall Survival (OS);	—

Secondary

Measure	Time frame
Tumor Marker;	—

Countries

China

Contacts

Public ContactChen Wenzhi

chenwz@cqmu.edu.cn+86 23 68485021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026